Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
US Stock MarketDetailed Quotes
Humacyte (HUMA)
- 1.060
- -0.020-1.85%
Close May 8 16:00 ET
- 1.041
- -0.019-1.76%
Post 20:01 ET
235.34MMarket Cap-4.08P/E (TTM)
1.090High1.010Low5.59MVolume1.070Open1.080Prev Close5.85MTurnover3.02%Turnover RatioLossP/E (Static)222.02MShares2.93052wk High75.71P/B195.90MFloat Cap0.54752wk Low--Dividend TTM184.81MShs Float17.450Historical High--Div Yield TTM7.41%Range %0.547Historical Low1.048Avg Price1Lot Size
About Humacyte Company
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Company Profile
SymbolHUMA
Company NameHumacyte
Listing DateDec 1, 2020
ISINUS44486Q1031
Founded2004
CEODr. Laura E. Niklason, M.D.,PhD
MarketNASDAQ
Employees184
Fiscal Year Ends12-31
Address2525 East North Carolina Highway 54
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-313-9633
Websitehttp://humacyte.com
Company Executives
- Name
- Position
- Salary
- Dr. Laura E. Niklason, M.D.,PhD
- President, Chief Executive Officer and Director
- 5.23M
- Shamik J. Parikh
- Chief Medical Officer
- 2.10M
- Dale A. Sander
- Principal Accounting Officer, Chief Financial Officer, Chief Corporate Development Officer and Treasurer
- 2.13M
- Kathleen Sebelius
- Chairman of the Board
- 227.80K
- Brady W. Dougan
- Director
- 202.80K
- Diane Seimetz, PhD
- Independent Director
- 202.80K
- Todd M. Pope
- Independent Director
- 207.80K
- Michael T. Constantino
- Independent Director
- 210.30K
- C. Bruce Green, M.D.
- Independent Director
- 202.80K
- Dr. Susan Richards Windham-Bannister, PhD
- Independent Director
- 207.80K
- Dr. Max Wallace, J.D.
- Independent Director
- 207.80K
- Dr. Keith Anthony Jones, M.D.
- Independent Director
- 202.80K
- Dr. John P. Bamforth
- Independent Director
- 202.80K
- Dr. Emery N. Brown, M.D.,PhD
- Independent Director
- 202.80K
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm